Suscribirse

Human Papillomavirus as Nontraditional Cardiovascular Risk Factor: Fact or Fiction? Part 2 - 22/11/24

Doi : 10.1016/j.amjmed.2024.07.014 
Leonard Palatnic, DO a, Jitae A. Kim, MD b, Sophie Y. Kim, MD c, Errol Moras, MD d, Kayla Cagle-Colon, MD, FACOG e, Daniel S. Kapp, MD, PhD f, Chayakrit Krittanawong, MD, FACC g,
a Department of Internal Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 
b Division of Cardiovascular Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 
c Department of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, El Paso 
d Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 
e Department of Obstetrics and Gynecology, Cherokee Nation Health Services, Tahlequah, OK 
f Department of Radiation Oncology, Stanford University, Calif 
g Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY 

Requests for reprints should be addressed to Chayakrit Krittanawong, MD, Cardiology Division, NYU School of Medicine, 550 First Avenue, New York, NY 10016.Cardiology DivisionNYU School of Medicine550 First AvenueNew YorkNY10016

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted infection in the US and worldwide, with more than 42 million Americans infected with types of HPV that are known to cause disease. While the link between HPV and the development of a variety of cancers has been strongly established, recent literature has demonstrated a potential association between HPV and increased risk of cardiovascular disease. Nevertheless, despite plausible mechanisms for the development of cardiovascular disease with HPV infection, a causative relationship has yet to be firmly established, in part due to potential confounding risk factors between the two. In this 2-part series, we discuss the emerging relationship between HPV and cardiovascular disease. In part 2, we focus on novel risk factors for HPV infection and cardiovascular disease including adverse childhood events, socioeconomic status, and immunosuppression. We conclude with potential prevention and treatment strategies for HPV-related cardiovascular disease, as well as the future direction of the research.

El texto completo de este artículo está disponible en PDF.

Keywords : Atherosclerosis, Cardiovascular disease, Human papillomavirus, Prevention


Esquema


 Funding: None.
 Conflict of Interest: None.
 Authorship: All authors had a role in writing/proofreading the manuscript and contributed to its final form. LP: Writing – original draft. JAK: Conceptualization, Writing – review & editing. SYK: Conceptualization, Writing – review & editing. EM: Writing – review & editing. KC-C: Writing – review & editing. DSK: Supervision, Writing – review & editing. CK: Writing – review & editing.


© 2024  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 137 - N° 12

P. 1170-1175 - décembre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Circulating Tumor DNA for Solid Tumor Minimal/Molecular Residual Disease Detection in Cancer Survivors
  • Steven Sorscher
| Artículo siguiente Artículo siguiente
  • Blood Pressure/Heart Rate-Derived Ratios as Indices of Health and Cardiovascular Pathology
  • John E. Madias

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.